FDA Inspection
Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned CompanyHospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company – FDA Inspection, Dec 16, 2025
Record Details
This FDA Inspection record concerns Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company, with an inspection on December 16, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 16, 2025
- Product Type
- Drugs
View Company Profile
ID · c377caf1-e094-4ecc-ae97-c89fbf90c69b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1299432
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
5| Date | Classification | Office | Project area |
|---|---|---|---|
| January 29, 2019 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| January 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 3, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 18, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2009 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
- FDA Inspection 1080179 - 2019-01-29
- FDA Inspection 1037953 - 2018-01-09
- FDA Inspection 830471 - 2013-05-03
- FDA Inspection 766688 - 2012-01-18
- FDA Inspection 613021 - 2009-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.